Japanese late-onset breast cancer families: Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations

Takehiro Okumura, Takashi Fukutomi, Hitoshi Tsuda, Yae Kanai, Toshikazu Ushijima, Sadako Akashi-Tanaka, Takeshi Nanasawa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The causes and pathologic and prognostic phenotypes of late-onset familial breast cancers are still unknown. The purpose of this study was to document the clinicopathological features of late-onset familial breast cancers using genetic testing of BRCA1 and BRCA2. Methods: We analyzed 11 breast cancers from 10 patients from 8 Japanese late-onset Breast cancer families. Results: The average age of the patients was 55 years (range 43 to 89). Bilateral occurrence was noted in 2 patients (8%). All the tumors were invasive ductal carcinomas, except for 1 case of invasive lobular carcinoma. Tumor size ranged from 0.8 cm to 7.8 cm (median 2.3 cm) and lymph node metastasis occurred in 6 of the 11 patients (55%). Six (55%) of the 11 tumors were histologically grade 2 and 5 (45%) were histologically grade 3. Estrogen receptor (ER) positivity was 80% (8/10). Overexpression of c-erbB-2 and p53 protein was detected in 18% (2/11) and 9% (1/11) of the tumors, respectively. Five patients from 4 families received genetic testing but all were negative for BRCA 1 and BRCA2 germline mutations. All the patients were alive after a median follow-up period of 32 months, except for 1 patient. Conclusions: In this study, no germline mutations of BRCA1 or BRCA2 were detected. However, there was a tendency towards ER-positive tumors, but the positivity of p53 protein was considered to be lower then that of sporadic tumors.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalBreast Cancer
Volume5
Issue number3
DOIs
Publication statusPublished - 1998 Jul
Externally publishedYes

Fingerprint

Germ-Line Mutation
Breast Neoplasms
Neoplasms
Genetic Testing
Estrogen Receptors
ErbB-2 Receptor
Lobular Carcinoma
Ductal Carcinoma
Lymph Nodes
Neoplasm Metastasis
Phenotype

Keywords

  • BRCA1
  • BRCA2
  • Familial breast cancer
  • Late-onset

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Cite this

Japanese late-onset breast cancer families : Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations. / Okumura, Takehiro; Fukutomi, Takashi; Tsuda, Hitoshi; Kanai, Yae; Ushijima, Toshikazu; Akashi-Tanaka, Sadako; Nanasawa, Takeshi.

In: Breast Cancer, Vol. 5, No. 3, 07.1998, p. 251-254.

Research output: Contribution to journalArticle

Okumura, Takehiro ; Fukutomi, Takashi ; Tsuda, Hitoshi ; Kanai, Yae ; Ushijima, Toshikazu ; Akashi-Tanaka, Sadako ; Nanasawa, Takeshi. / Japanese late-onset breast cancer families : Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations. In: Breast Cancer. 1998 ; Vol. 5, No. 3. pp. 251-254.
@article{386f93feccda470c8af49f44a3d64dd2,
title = "Japanese late-onset breast cancer families: Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations",
abstract = "Background: The causes and pathologic and prognostic phenotypes of late-onset familial breast cancers are still unknown. The purpose of this study was to document the clinicopathological features of late-onset familial breast cancers using genetic testing of BRCA1 and BRCA2. Methods: We analyzed 11 breast cancers from 10 patients from 8 Japanese late-onset Breast cancer families. Results: The average age of the patients was 55 years (range 43 to 89). Bilateral occurrence was noted in 2 patients (8{\%}). All the tumors were invasive ductal carcinomas, except for 1 case of invasive lobular carcinoma. Tumor size ranged from 0.8 cm to 7.8 cm (median 2.3 cm) and lymph node metastasis occurred in 6 of the 11 patients (55{\%}). Six (55{\%}) of the 11 tumors were histologically grade 2 and 5 (45{\%}) were histologically grade 3. Estrogen receptor (ER) positivity was 80{\%} (8/10). Overexpression of c-erbB-2 and p53 protein was detected in 18{\%} (2/11) and 9{\%} (1/11) of the tumors, respectively. Five patients from 4 families received genetic testing but all were negative for BRCA 1 and BRCA2 germline mutations. All the patients were alive after a median follow-up period of 32 months, except for 1 patient. Conclusions: In this study, no germline mutations of BRCA1 or BRCA2 were detected. However, there was a tendency towards ER-positive tumors, but the positivity of p53 protein was considered to be lower then that of sporadic tumors.",
keywords = "BRCA1, BRCA2, Familial breast cancer, Late-onset",
author = "Takehiro Okumura and Takashi Fukutomi and Hitoshi Tsuda and Yae Kanai and Toshikazu Ushijima and Sadako Akashi-Tanaka and Takeshi Nanasawa",
year = "1998",
month = "7",
doi = "10.1007/BF02966704",
language = "English",
volume = "5",
pages = "251--254",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Japanese late-onset breast cancer families

T2 - Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations

AU - Okumura, Takehiro

AU - Fukutomi, Takashi

AU - Tsuda, Hitoshi

AU - Kanai, Yae

AU - Ushijima, Toshikazu

AU - Akashi-Tanaka, Sadako

AU - Nanasawa, Takeshi

PY - 1998/7

Y1 - 1998/7

N2 - Background: The causes and pathologic and prognostic phenotypes of late-onset familial breast cancers are still unknown. The purpose of this study was to document the clinicopathological features of late-onset familial breast cancers using genetic testing of BRCA1 and BRCA2. Methods: We analyzed 11 breast cancers from 10 patients from 8 Japanese late-onset Breast cancer families. Results: The average age of the patients was 55 years (range 43 to 89). Bilateral occurrence was noted in 2 patients (8%). All the tumors were invasive ductal carcinomas, except for 1 case of invasive lobular carcinoma. Tumor size ranged from 0.8 cm to 7.8 cm (median 2.3 cm) and lymph node metastasis occurred in 6 of the 11 patients (55%). Six (55%) of the 11 tumors were histologically grade 2 and 5 (45%) were histologically grade 3. Estrogen receptor (ER) positivity was 80% (8/10). Overexpression of c-erbB-2 and p53 protein was detected in 18% (2/11) and 9% (1/11) of the tumors, respectively. Five patients from 4 families received genetic testing but all were negative for BRCA 1 and BRCA2 germline mutations. All the patients were alive after a median follow-up period of 32 months, except for 1 patient. Conclusions: In this study, no germline mutations of BRCA1 or BRCA2 were detected. However, there was a tendency towards ER-positive tumors, but the positivity of p53 protein was considered to be lower then that of sporadic tumors.

AB - Background: The causes and pathologic and prognostic phenotypes of late-onset familial breast cancers are still unknown. The purpose of this study was to document the clinicopathological features of late-onset familial breast cancers using genetic testing of BRCA1 and BRCA2. Methods: We analyzed 11 breast cancers from 10 patients from 8 Japanese late-onset Breast cancer families. Results: The average age of the patients was 55 years (range 43 to 89). Bilateral occurrence was noted in 2 patients (8%). All the tumors were invasive ductal carcinomas, except for 1 case of invasive lobular carcinoma. Tumor size ranged from 0.8 cm to 7.8 cm (median 2.3 cm) and lymph node metastasis occurred in 6 of the 11 patients (55%). Six (55%) of the 11 tumors were histologically grade 2 and 5 (45%) were histologically grade 3. Estrogen receptor (ER) positivity was 80% (8/10). Overexpression of c-erbB-2 and p53 protein was detected in 18% (2/11) and 9% (1/11) of the tumors, respectively. Five patients from 4 families received genetic testing but all were negative for BRCA 1 and BRCA2 germline mutations. All the patients were alive after a median follow-up period of 32 months, except for 1 patient. Conclusions: In this study, no germline mutations of BRCA1 or BRCA2 were detected. However, there was a tendency towards ER-positive tumors, but the positivity of p53 protein was considered to be lower then that of sporadic tumors.

KW - BRCA1

KW - BRCA2

KW - Familial breast cancer

KW - Late-onset

UR - http://www.scopus.com/inward/record.url?scp=0006978413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0006978413&partnerID=8YFLogxK

U2 - 10.1007/BF02966704

DO - 10.1007/BF02966704

M3 - Article

C2 - 18841336

AN - SCOPUS:0006978413

VL - 5

SP - 251

EP - 254

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 3

ER -